Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001062993-22-019753)

Filing Details

Accession Number:: 0001062993-22-019753
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-20 06:54:26
Reporting Period:: 2022-09-16

Accepted Time:: 2022-09-20 06:54:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374690	Larimar Therapeutics Inc.	LRMR	Pharmaceutical Preparations (2834)	203857670

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769848	Edward Thomas Hamilton	C/O Larimar Therapeutics, Inc. Three Bala Plaza East, Suite 506 Bala Cynwyd PA 19004		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-16	317,460	$3.15	507,590	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	159,433	Indirect	FA Life Sciences, Inc.

Footnotes

Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.